Allscripts Healthcare Solutions (MDRX) Releases FY 2019 Earnings Guidance

Allscripts Healthcare Solutions (NASDAQ:MDRX) issued an update on its FY 2019 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $0.65-0.70 for the period, compared to the Thomson Reuters consensus estimate of $0.67. Allscripts Healthcare Solutions also updated its FY19 guidance to $0.65 to $0.70 EPS.

MDRX stock traded up $0.49 during midday trading on Friday, reaching $10.43. The company’s stock had a trading volume of 3,127,582 shares, compared to its average volume of 2,292,220. The company has a quick ratio of 1.08, a current ratio of 1.08 and a debt-to-equity ratio of 0.41. Allscripts Healthcare Solutions has a 1 year low of $8.54 and a 1 year high of $14.97. The firm has a market cap of $1.73 billion, a price-to-earnings ratio of 18.96, a PEG ratio of 1.93 and a beta of 1.29.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last released its earnings results on Thursday, May 2nd. The software maker reported $0.16 earnings per share for the quarter, topping analysts’ consensus estimates of $0.14 by $0.02. Allscripts Healthcare Solutions had a return on equity of 7.74% and a net margin of 18.15%. The business had revenue of $432.00 million for the quarter, compared to analyst estimates of $436.47 million. During the same quarter last year, the firm posted $0.16 earnings per share. The business’s revenue was down .4% compared to the same quarter last year. Research analysts expect that Allscripts Healthcare Solutions will post 0.5 EPS for the current year.

MDRX has been the topic of a number of recent analyst reports. ValuEngine lowered Allscripts Healthcare Solutions from a hold rating to a sell rating in a research note on Monday, April 1st. Citigroup lowered Allscripts Healthcare Solutions from a buy rating to a neutral rating and reduced their target price for the stock from $14.00 to $12.00 in a research note on Friday, February 22nd. BidaskClub lowered Allscripts Healthcare Solutions from a buy rating to a hold rating in a research note on Saturday, February 23rd. Finally, Zacks Investment Research upgraded Allscripts Healthcare Solutions from a sell rating to a hold rating in a research note on Monday, January 21st. One analyst has rated the stock with a sell rating, seven have issued a hold rating and five have assigned a buy rating to the company’s stock. Allscripts Healthcare Solutions presently has an average rating of Hold and a consensus price target of $14.13.

ILLEGAL ACTIVITY NOTICE: This piece was originally posted by Baseball Daily News and is owned by of Baseball Daily News. If you are reading this piece on another publication, it was copied illegally and republished in violation of US & international copyright and trademark laws. The legal version of this piece can be read at https://www.baseballdailydigest.com/news/2019/05/04/allscripts-healthcare-solutions-mdrx-releases-fy-2019-earnings-guidance.html.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions.

Further Reading: Preferred Stock

Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.